WO1992017580A1 - Chimeric plant genes based on upstream regulatory elements of helianthinin - Google Patents

Chimeric plant genes based on upstream regulatory elements of helianthinin Download PDF

Info

Publication number
WO1992017580A1
WO1992017580A1 PCT/US1992/002822 US9202822W WO9217580A1 WO 1992017580 A1 WO1992017580 A1 WO 1992017580A1 US 9202822 W US9202822 W US 9202822W WO 9217580 A1 WO9217580 A1 WO 9217580A1
Authority
WO
WIPO (PCT)
Prior art keywords
gene
plant
expression
helianthinin
hag3
Prior art date
Application number
PCT/US1992/002822
Other languages
French (fr)
Inventor
Terry Thomas
Georges Freyssinet
Michel Lebrun
Molly Bogue
Original Assignee
Rhone-Poulenc Agrochimie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone-Poulenc Agrochimie filed Critical Rhone-Poulenc Agrochimie
Priority to KR1019930703055A priority Critical patent/KR100228918B1/en
Priority to JP4509101A priority patent/JPH06509939A/en
Priority to AU16819/92A priority patent/AU672949B2/en
Priority to BR9205873A priority patent/BR9205873A/en
Priority to CA002107583A priority patent/CA2107583A1/en
Priority to UA93003973A priority patent/UA44217C2/en
Publication of WO1992017580A1 publication Critical patent/WO1992017580A1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/415Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from plants
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/8223Vegetative tissue-specific promoters
    • C12N15/8227Root-specific
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8222Developmentally regulated expression systems, tissue, organ specific, temporal or spatial regulation
    • C12N15/823Reproductive tissue-specific promoters
    • C12N15/8234Seed-specific, e.g. embryo, endosperm
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09Recombinant DNA-technology
    • C12N15/63Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8237Externally regulated expression systems
    • C12N15/8238Externally regulated expression systems chemically inducible, e.g. tetracycline
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)

Abstract

Helianthinin is an 11S seed storage protein of sunflower embryos. The present invention is directed to the 5' regulatory regions of helianthinin genes. More particularly, the present invention is directed to specific cis-regulatory elements of this regulatory region which direct tissue-specific, temporally-regulated, or abscisic acid-responsive gene expression. The present invention provides chimeric genes comprising the cis-regulatory elements linked to a coding sequence from a heterologous gene to control expression of these genes. The chimeric genes provided by the instant invention are useful in conferring herbicide resistance and improved seed lipid quality to transgenic plants.

Description

CHIMERIC PLANT GENES BASED ON UPSTREAM
REGULATORY ELEMENTS OF HELIANTHININ
Helianthinin is an IIS seed storage protein of sunflower embryos. The present invention is directed to the 5' regulatory regions of helianthinin genes. More particularly, the present invention is directed to specific cis-regulatory elements of this regulatory region which direct tissue-specific, temporally-regulated, or abscisic acid-responsive gene expression. The present invention provides chimeric genes comprising the cis-regulatory elements linked to a coding sequence from a heterologous gene to control expression of these genes. The chimeric genes provided by the instant invention are useful in conferring herbicide resistance and improved seed lipid quality to transgenic plants.
Seed development, unique to higher plants, involves embryo development as well as physiological adaptation processes that occur within the seed to ensure the survival of the developing seedling upon germination. After fertilization, there is rapid growth and differentiation of the embryo and endosperm, after which nutritive reserves accumulate during the maturation stage of seed development. These reserves are stored during a period of developmental arrest for later use by the developing seedling. This period of arrest occurs prior to the desiccation phase of seed development.
Several classes of seed proteins, including storage proteins, lectins, and trypsin inhibitors, accumulate during embryogenesis. The main function of seed storage proteins is to accumulate during embryogenesis and to store carbon and nitrogen reserves for the developing seedling upon germination. These proteins, as well as many of the genes encoding them, have been studied extensively (for review see Shotwell et al. (1989) in The Biochemistry of Plants, 15, Academic Press, NY, 297). Genes encoding seed storage proteins are highly regulated and differentially expressed during seed development. Expression is temporally regulated with mRNA accumulatin rapidly during the maturation phase of embryogenesis. This expression is also tissue-specific, occurring primarily in the cotyledons or endosperm of the developing seeds. The resulting storage proteins are processed and targeted to protein bodies, in which the storage proteins remain during desiccation and dormancy of the embryo. Upon germination, the seedling uses these storage proteins as a source of carbon and nitrogen (Higgins (1984) Ann. Rev. Plant Physiol. 35, 191).
Seed proteins, including storage proteins, lectins and trypsin inhibitors, are encoded by nonhomologous multigene families that are not amplified or structurally altered during development (for review see Goldberg et al. (1989) Cell 56, 149). These genes are temporally and spatially regulated but not necessarily linked. Although post-transcriptional mechanisms act to control the accumulation of some of these proteins, regulation occurs primarily at the transcriptional level. Accordingly, seed protein genes provide an excellent system to provide genetic regulatory elements, especially those elements which confer tissue specificity, temporal regulation, and responsiveness to environmental and chemical cues.
Observations of temporal and spatial regulation of seed protein genes has suggested that seed protein genes are regulated in part by common cellular factors known as trans- acting factors. However, since quantitative and qualitative differences exist in the expression patterns of individual seed protein genes, more specific factors must also exist to provide a means for differential expression patterns between these groups of seed proteins. Patterns of differential expression have been observed between the rapeseed major seed storage proteins, cruciferin and napin (Crouch et al. (1981) Planta 153, 64; Finkelstein et al. (1985) Plant Physiol. 78, 630), and among individual members of the soybean Kunitz trypsin inhibitor gene family (Jofuku et al. (1989) Plant Cell 1, 1079). A comparison of the soybean major seed storage protein genes showed a difference in timing and cell-type specificity of the expression of ß-conglycinin (7S) and glycinin (11S). The 7S subunit mRNA appeared several days before the 11S mRNA. Furthermore, while members of the glycinin gene family were all activated simultaneously (Nielsen et al. (1989) Plant Cell 1 , 313), members of the ß-conglycinin gene family were differentially regulated (Barker et al. (1988) Proc. Natl. Acad. Sci. USA 85, 458; Chen et al. (1989) Dev. Genet. 10, 112). Each of these genes contain a different array of cis-regulatory elements which confer differential expression patterns between, and within, these gene families.
Helianthinin is the major 11S globulin seed storage protein of sunflower (Helianthus annuus). Helianthinin expression, like that of other seed storage proteins, is tissue specific and under developmental control. However, the helianthin regulatory elements which confer such specificity have heretofore never been identified. Helianthinin mRNA is first detected in embryos 7 days post flowering (DPF) with maximum levels of mRNA reached at 12-15 DPF, after which the level of helianthinin transcripts begins to decline. In mature seeds or in germinating seedlings helianthinin transcripts are absent. Helianthinin polypeptide accumulation is rapid from DPF through 19 DPF but slows as the seed reaches later maturation stages (Allen et al. (1985) Plant Mol. Biol. 5, 165).
Helianthinin, like most seed proteins, is encoded by a small gene family. At least two divergent subfamilies are known, and are designated Ha2 and Ha10. Two clones, HaG3-A and HaG3-D, representing non-allelic members of the Ha2 subfamily, have been isolated and partially characterized (Vonder Haar et al. (1988) Gene 74, 433). However, a detailed analysis of the regulatory elements of these or any other helianthinin genes had not been known until now.
It has been found in accordance with the present invention that regulatory elements from helianthinin genes can direct seed-specific gene expression, root-specific gene expression, abscisic acid-responsive gene expression, and/or temporally-altered gene expression. These regulatory elements enable the controlled expression of specific gene products in transgenic plants. The present invention provides greater control of gene expression in transgenic plants, thus allowing improved seed quality, improved tolerance to environmental conditions such as drought, and better control of herbicide resistance genes.
The present invention is directed to the 5 regulatory region of a helianthinin gene. This region is herein referred to as the upstream regulatory ensemble (URE), and is useful in directing the expression of heterologous proteins. The URE consists of multiple regulatory elements which confer distinct regulated expression patterns when linked to the coding regions of heterologous genes which are expressed in transgenic plants.
In particular, the present invention provides isolated DNA containing helianthinin regulatory elements which direct seed-specific gene expression, root-specific gene expression, abscisic acid (ABA)-responsive gene expression and/or temporally-altered gene expression.
Another aspect of this invention is directed to chimeric plant genes containing these regulatory elements. The regulatory elements are operably linked to the coding sequence of a heterologous gene such that the regulatory element is capable of controlling expression of the product encoded by the heterologous gene. If necessary, additional promoter elements or parts of these elements are included in the chimeric gene constructs. Plant transformation vectors comprising the chimeric genes of the present invention are also provided, as are plant cells transformed by these vectors, and plants and their progeny containing the chimeric genes.
In yet another aspect of this invention, a method is provided for producing a plant with improved seed-lipid quality. Chimeric ge are constructed according to the present invention in which a regulatory element directing seed-specific expression is linked to the coding region of a gene encoding a lipid metabolism enzyme. When plant cells are transformed with this chimeric gene, plants with improved seed lipid-quality can be regenerated.
A further aspect of the present invention provides a method for producing a herbicide-resistant plant. In accordance with the present invention, for example, chimeric genes are constructed in which a root-specific regulatory element directs the expression of herbicide-resistance gene. Plant cells are transformed with this chimeric gene to regenerate herbicide-resistant plants.
Fig. 1 depicts the nucleotide sequence of the URE of helianthinin gene HaG3-A. Nucleotide numbers -2377 to +24 of Fig. 1 correspond to nucleotide numbers 1 to 2401 of SEQ ID NO: 1.
Fig. 2 depicts the nucleotide sequence of part of the URE of helianthinin gene HaG3-D. Nucleotide numbers -2457 to -726 of Fig. 2 correspond to nucleotide numbers 1 to 1732 of SEQ ID NO: 2.
Fig. 3 represents the nucleotide sequence of part of the URE of helianthinin gene HaG3-D. Nucleotide numbers -725 to -322 of Fig. 3 correspond to nucleotide numbers 1 to 404 of SEQ ID NO: 3. In the helianthinin gene HaG3-D, the nucleotide sequence of Fig. 3 is immediately downstream (3') of the sequence of Fig. 2. Fig. 4 depicts the HaG3-A FL/GUS construction and the control constructions pBI121.1 and pBI101.1.
Fig. 5 depicts a restriction map of helianthinin genomic clones HaG3-A and HaG3-D and the restriction fragments used to construct the parental plasmids.
Fig. 6 depicts the HaG3-A and HaG3-D derivative constructions in relation to the full length construction.
Fig. 7 demonstrates histochemical localization of GUS activity in transgenic seedlings containing the HaG3-D-N and HaG3-A-SB/R constructions. A: HaG3-D-404N, 8 days post- imbibition (DPI); B: HaG3-A-SB/R, 8 DPI; C: HaG3-D-404N, 14 DPI; D: HaG3-A-SB/R, 14 DPI; E: HaG3-A-SB/R, 8 DPI; F: HaG3-A-SB/R, 6 DPI.
Fig. 8 graphically illustrates the induction of GUS activity in transgenic tobacco leaves containing HaG3-D-404N during progressive desiccation and subsequent recovery from water deficit.
Fig. 9 is a graph depicting ABA induction of GUS expression in leaves of tobacco containing HaG3-D-404N.
The present invention comprises cis-regulatory elements of the upstream regulatory ensemble (URE) of sunflower helianthinin genes. These cis-regulatory elements are discrete regions of the URE that confer regulated expression upon the gene under their control. In particular, this invention provides isolated nucleic acid containing at least one regulatory element from a helianthinin gene which directs at least one of the following: seed-specific gene expression, root-specific gene expression, ABA-responsive gene expression or temporally-altered gene expression. Any helianthinin gene can provide the regulatory elements, including Ha2 and Ha10 genes, which represent two divergent helianthinin gene subfamilies. In a preferred embodiment, the helianthinin genes are HaG3-A and HaG3-D, which are members of the Ha2 subfamily. One of the subject regulatory elements directs seed-specific expression. A seed-specific regulatory element represents a particular nucleotide sequence that is capable of causing the expression of the gene under its control to occur in the seed, i.e. for the gene produced to be detected in the seed. Expression that is seed-specific may be in any part of the seed, e.g., but not limited to, the cotyledons and embryonic axis of the embryo and to the endosperm. No gene expression is detected in seedlings or somatic tissues of the adult plant for genes under seed-specific control.
To identify regulatory elements that direct seed-specific expression, a deletion analysis of the entire URE of a helianthinin gene can be performed. In a deletion analysis, nucleotides are successively removed from the entire URE, and the resulting fragments are ligated to the coding sequence of a reporter gene or other heterologous gene. The constructs are then analyzed for their ability to direct seed-specific expression by detecting the presence of the reporter gene product in seed tissues and not in other tissues. The seed- specific elements which have been identified can also be modified, e.g. by site-directed mutagenesis. The modified regulatory elements can then be assayed for their ability to direct seed-specific expression, thereby identifying alternative sequences that confer seed-specificity. These techniques for identifying regulatory elements are applicable to all helianthinin genes. For example, in a preferred embodiment an analysis of the URE of the helianthinin HaG3-A gene indicates that seed-specific regulatory elements are provided by nucleotides 851 to 2401, and by nucleotides 1 to 2401 of SEQ ID NO: 1.
Other regulatory elements provided by the present invention provide root-specific expression. Root-specific expression is of particular interest and importance. Normally the sunflower helianthinin gene is expressed only in seeds. When particular regions of the helianthinin URE are isolated from the entire URE in accordance with the present invention, expression is exclusively localized to plant roots. A root- specific regulatory element represents a particular nucleotide sequence that is capable of causing the expression of the gene under its control to occur in plant roots and not in other plant tissues. Regulatory elements that direct root-specific expression are identified by analyzing fragments of a helianthinin URE for their ability to confer root-specific expression as described above for the identification of seed- specific regulatory elements except expression is detected in root tissues. Modifications of the nucleotide sequences that permit root-specific expression are also identified as described above. Root-specific regulatory elements from any helianthinin gene can be identified by such techniques. For example, in a preferred embodiment, an analysis of the URE of the helianthinin HaG3-A gene indicates that nucleotides 1 to 1639 and nucleotides 851 to 1639 of SEQ ID NO: 1 represent root-specific regulatory elements.
Helianthinin expression is under strict temporal control, with mRNA first detected at 12 DPF. Accordingly, it has been discovered that cis-regulatory elements exist which confer temporally-altered gene expression which is detectable as early as about 4 DPF.
To identify regulatory elements that confer temporally-altered gene expression, a deletion analysis of the entire URE of a helianthinin gene can be performed. Fragments of the URE are linked to the coding sequence of a heterologous gene and the resulting chimeric construction is used to transform plants. Seeds from transformed plants are staged by days post flowering, and the staged seeds are assayed to detect the expression of the heterologous gene. Elements that direct expression of the heterologous gene before about 10 DPF are identified as elements that confer temporally-altered expression. Modifications of the nucleotide sequences of such elements that confer the desired phenotype can be identified as described above. These techniques for identification of regulatory elements that confer temporally-altered gene expression are applicable to all helianthinin genes. In a preferred embodiment, an analysis of the URE of the helianthinin gene HaG3-A indicates that elements that confer temporally-altered gene expression are provided by nucleotide 1 to 851 and 1639 to 2303 of SEQ ID NO: 1.
Another aspect of the present invention is directed to regions of the URE of helianthinin that confer abscisic acid (ABA) -responsive gene expression. An ABA-responsive element represents a particular nucleotide sequence that is capable of causing the gene under its control to be expressed in response to ABA. Expression of the gene under the control of the ABA-responsive element can be induced by treatment with ABA, or by external stimuli that are known to result in the initiation of ABA biosynthesis. For example, ABA biosynthesis is initiated as a result of loss of turgor caused by environmental stresses including water-deficit, water-stress and salt-stress (reviewed in Zeevaart et al. (1988) Annu. Rev. Plant Physiol. 39, 439). Levels of ABA also increase in response to wounding, (Pena-Cortes et al. (1989) Proc. Natl. Acad Sci. USA 86, 9851).
ABA-responsive elements are identified as described above for the identification of other regulatory elements. For example, deletion analysis can be used to identify nucleotide sequences of any helianthinin gene that induce the expression of a gene under its control in response to ABA. Such sequences can be modified as described above, and assayed to identify alternative sequences that confer ABA-responsive expression. In one preferred embodiment, an analysis of the URE of the helianthinin HaG3-A gene indicates that nucleotides 1 to 2401 of SEQ ID NO: 1 provide an element that confers ABA-responsive expression in seeds. In another preferred embodiment, nucleotides 851 to 1639 or 1639 to 2303 of SEQ ID NO: 1 provide an element that confers ABA-responsive expression in leaves of adult plants. In yet another preferred embodiment, an analysis of the URE of the helianthinin HaG3-D gene indicates that nucleotides 1 to 404 of SEQ ID NO: 3 confer ABA-responsive expression in non-embryonic tissues of plants.
Accordingly, ABA-responsive elements have utility in that specific environmental cues can initiate ABA biosynthesis, and further induce expression of genes under the control of an ABA-responsive element. Expression of heterologous genes driven by the ABA-responsive elements of the helianthinin URE is not restricted to seeds, but is also observed in leaves of adult plants and in tissues of seedlings.
An isolated nucleic acid encoding the upstream regulatory ensemble of a helianthinin gene can be provided as follows. Helianthinin recombinant genomic clones are isolated by screening a sunflower genomic DNA library with a cDNA recombinant representing helianthinin mRNA (Vonder Haar (1988) Gene 74, 433). Methods considered useful in obtaining helianthinin genomic recombinant DNA are contained in Sambrook et al., 1989, in Molecular Cloning: A Laboratory Manual, Cold Spring Harbor, NY, for example, or any of the myriad of laboratory manuals on recombinant DNA technology that are widely available. To determine nucleotide sequences, a multitude of techniques are available and known to the ordinarily skilled artisan. For example, restriction fragments containing a helianthinin URE can be subcloned into the polylinker site of a sequencing vector such as pBluescript (Stratagene). These pBluescript subclones can then be sequenced by the double-strand dideoxy method (Chen and Seeburg (1985) DNA 4 , 165). The nucleotide sequence for DNA encoding the URE of helianthinin gene clone HaG3A is shown in Fig. 1 and presented as SEQ ID NO: 1. Similarly, the nucleotide sequence for DNA encoding a region of the URE of helianthinin clone HaG3D is shown in Fig. 2 and presented as nucleotide sequence SEQ ID NO: 2. The UREs of other helianthinin genes can be obtained by the same strategy. Alternatively, clones representative of other members of the helianthinin gene family can be obtained by using the HaG3A or HaG3D coding or URE sequences of the present invention as hybridization probes to screen a helianthinin genomic library and identify the additional helianthinin genes.
The identification of cis-regulatory sequences that direct temporal, tissue-specific and ABA-responsive regulation can be accomplished by transcriptional fusions of specific sequences with the coding sequence of a heterologous gene, transfer of the chimeric gene into an appropriate host, and detection of the expression of the heterologous gene. The assay used to detect expression depends upon the nature of the heterologous sequence. For example, reporter genes, exemplifed by chloramphenicol acetyl transferase and ß-glucuronidase (GUS), are commonly used to assess transcriptional and translational competence of chimeric constructions. Standard assays are available to sensitively detect the reporter enzyme in a transgenic organism. The ß-glucoronidase (GUS) gene is useful as a reporter of promoter activity in transgenic tobacco plants because of the high stability of the enzyme in tobacco cells, the lack of intrinsic ß-glucuronidase activity in higher plants and availability of a qualitative fluorimetric assay and a histochemical localization technique. Jefferson et al. [(1987) EMBO J, 6. 3901)] have established standard procedures for biochemical and histochemical detection of GUS activity in plant tissues. Biochemical assays are performed by mixing plant tissue lysates with 4-methylumbelliferyl-ß-D-glucuronide, a fluorimetric substrate for GUS, incubating one hour at 37°C, and then measuring the fluorescence of the resulting 4-methylumbelliferone. Histochemical localization for GUS activity is determined by incubating plant tissue samples in 5-bromo-4- chloro-3-indolyl-glucuronide (X-Gluc) for 18 hours at 37°C, and observing the staining pattern of X-Gluc. The construction of such chimeric genes allows definition of specific regulatory sequences required for regulation of expression, and demonstrates that these sequences can direct expression of heterologous genes in the manner under analysis.
Another aspect of the present invention is directed to a chimeric plant gene containing a regulatory element from a helianthinin gene which directs seed-specific gene expression, root-specific gene expression, ABA-responsive gene expression or temporally-altered gene expression linked to the coding sequence of a heterologous gene such that the regulatory element is capable of controlling expression of the product encoded by the heterologous gene. The heterologous gene can be any gene other than helianthinin. If necessary, additional promoter elements or parts of these elements sufficient to cause expression resulting in production of an effective amount of the polypeptide encoded by the heterologous gene are included in the chimeric constructs.
Accordingly, the present invention provides chimeric genes comprising regions of the helianthinin URE that confer seed-specific expression in accordance with this invention which are linked to a sequence encoding a lipid metabolism enzyme such as a desaturase. In a preferred embodiment, the regions of the URE comprise nucleotides 851 to 2401 or 1 to 2401 of HaG3-A as shown in SEQ ID NO:1. Any modification of these sequences which confers seed-specific expression is contemplated. Seeds accumulate and store proteins and lipids, both of significant agronomic importance. Because elements of the helianthinin URE can direct high, regulated expression in developing seeds, these elements have utility in improving seed lipid and/or protein quality. These elements are useful in regulating expression of genes encoding lipid metabolism enzymes, such as those involved in elongation and desaturation of fatty acids, and/or proteins, especially those with high lysine and methionine content. Chimeric genes containing these elements can be used to provide transgenic plant lines that accumulate and store significant amounts of specific classes of lipids and/or proteins.
In another aspect of the present invention chimeric genes are provided which have a region of the URE of helianthinin that confers root-specific expression fused to a heterologous gene. This construction confers expression spatially distinct from "normal" helianthinin expression in that the heterologous gene is expressed exclusively in plant roots. In other words, when a specific sequence is removed from the context of the entire URE, tissue-specific regulation is altered. In a preferred embodiment, the region of the HaG3-A URE comprises 1 to 1639 or 851 to 1639 of SEQ ID NO: 1 and is fused in reverse orientation to the promoter although these elements function in either orientation. In another preferred embodiment the sequence providing herbicide resistance is at least part of the aroA gene. Any modification of these sequences which confers root-specific expression is contemplated.
Of particular importance is the use of these chimeric constructions to confer herbicide resistance. Since most herbicides do not distinguish between weeds and crop plants, the engineering of herbicide-resistant crop plants is of considerable agronomic importance in that it allows the use of broad-spectrum herbicides. Accordingly, the present invention provides chimeric genes comprising elements of a helianthinin URE that confer root-specific expression fused to at least part of a promoter that functions in plants and further fused to at least part of the aroA gene or a sequence encoding a polypeptide conferring herbicide resistance. Polypeptides that confer resistance to glyphosate and related inhibitors of 5-enolpyrovylshikimic acid-3-phosphate synthase (EPSP synthase), sulfonylureas, imidazolinones and inhibitors of acetolactase synthase (ALS) and acetohydroxy acid synthase (AHS) are contemplated. In a preferred embodiment the regions of the URE are 1 to 1639 or 851 to 1639 of HaG3-A, as shown in SEQ ID NO: 1 and are fused in reverse orientation to the promoter. Any modification of these sequences which confers root-specific expression is contemplated.
In another aspect of the present invention chimeric genes are provided comprising elements of the URE of helianthinin that confer temporally-altered expression fused in forward or reverse orientation to at least part of a promoter that functions in plants and further linked to the coding region of a heterologous gene. In a preferred embodiment the elements
of the URE are nucleotides 1 to 851 or 1639 to 2303 of HaG3-A, as shown in SEQ ID NO: 1. Any modification of these sequences that confers temporally altered gene expression is contemplated.
Chimeric genes are provided comprising elements of the URE of a helianthinin that confer ABA-responsive expression optionally fused in forward or reverse orientation to at least part of a promoter that functions in plants further fused to a heterologous gene. In a preferred embodiment the element of the URE comprises 851 to 1639 or 1639 to 2303 of HaG3-A, as shown in SEQ ID NO: 1, or nucleotides 1 to 404 of HaG3-D, as shown in SEQ ID NO: 3. Of particular importance is the use of constructs that confer ABA-responsive expression to provide plants with improved tolerance to water stress.
The chimeric genes of the present invention are constructed by fusing a 5' flanking sequence of a helianthinin genomic DNA to the coding sequence of a heterologous gene. The juxtaposition of these sequences can be accomplished in a variety of ways. In a preferred embodiment the order of sequences, from 5' to 3', is a helianthinin upstream regulatory region, a promoter region, a coding sequence, and a polyadenylation site.
Standard techniques for construction of such chimeric genes are well known to those of ordinary skill in the art and can be found in references such as Sambrook et al. (1989). A variety of strategies are available for ligating fragments of DNA, the choice of which depends on the nature of the termini of the DNA fragments. One of ordinary skill in the art recognizes that in order for the heterologous gene to be expressed, the construction requires promoter elements and signals for efficient polyadenylation of the transcript. Accordingly, the 5' helianthinin URE regions that contain the promoter sequences known as CAAT and TATA boxes can be fused directly to a promoterless heterologous coding sequence. Alternatively, the helianthinin URE regions that do not contain the CAAT and TATA boxes can be joined to a DNA fragment encoding a promoter that functions in plants. Plant promoters can be obtained commercially, or can be chemically synthesized based on their published sequences. An example of such a fragment is the truncated cauliflower mosaic virus 35S promoter, which retains its CAAT and TATA boxes. Other representative promoters include the nopaline synthase and ribulose 1,5 bisphosphate carboxylase promoters. The promoter fragment is further linked to the heterologous coding sequence. The 3' end of the coding sequence is fused to a polyadenylation site exemplified by, but not limited to, the nopaline synthase polyadenylation site. Furthermore, intermediate plant transformation vectors are available that contain one or more of these polyadenylation sites bordered by sequences required for plant transformation. The elements of the helianthinin URE and the heterologous coding sequences of the present invention can be subcloned into the polylinker site of a plant transformation vector to provide the chimeric genes.
The 5' flanking elements of the present invention can be derived from restriction endonuclease or exonuclease digestion of a helianthinin genomic clone. The restriction fragments that contain the helianthinin CAAT and TATA boxes are ligated in a forward orientation to a promoterless heterologous gene such as the coding sequence of ß-glucuronidase (GUS). The skilled artisan will recognize that the 5' helianthinin regulatory sequences can be provided by other means, for example chemical or enzymatic synthesis. The heterologous product can be the coding sequence of any gene that can be expressed in such a construction. Such embodiments are contemplated by the present invention. The 3' end of the coding sequence is optionally fused to a polyadenylation site, exemplified by, but not limited to, the nopaline synthase polyadenylation site, or the octopine T-DNA gene 7 polyadenylation site. Alternatively, the polyadenylation site can be provided by the heterologous gene.
The 5' helianthinin regulatory elements that do not contain the TATA box can be linked in forward or reverse orientation to at least part of a plant promoter sequence, i.e. a plant promoter sequence containing at least the CAAT and TATA sequences. In a preferred embodiment, this promoter is a truncated cauliflower mosaic virus (CaMV) 35S promoter. The resulting chimeric complex can be ligated to a heterologous coding sequence and a polyadenylation sequence.
To provide regulated expression of the heterologous genes, plants are transformed with the chimeric gene constructions of this invention. Gene transfer is well known in the art as a method to express heterologous genes in transgenic plants. The tobacco plant is most commonly used as a host because it is easily regenerated, yields a large number of developing seeds per plant, and can be transformed at a high frequency with Agrobacterium-derived Ti plasmid vectors (Klee, et al. (1987) Annu. Rev. Plant Physiol. 38, 467). Dicotyledenous plants including cotton, oil seed rape and soybean are preferred as transgenic hosts. However, one of ordinary skill in the art will recognize that any plant that can be effectively transformed and regenerated can be used as a transgenic host in the present invention.
A variety of transformation methods are known. The chimeric genes can be introduced into plants by a leaf disk transformation-regeneration procedure as described by Horsch et al. (1985) Science 227, 1229). Other methods of transformation, such as protoplast culture (Horsch et al., (1984) Science 223, 496; DeBlock et al. (1984) EMBO J. 2, 2143; Barton et al. (1983) Cell 32, 1033) or transformation of stem or root explants in vitro (Zambryski et al. (1983) EMBO J. 2 , 2143; Barton et al. (1983) Cell 32, 1033) can also be used and are within the scope of this invention. In a preferred embodiment plants are transformed with Agrobacterium-derived vectors. However, other methods are available to insert the chimeric genes of the present invention into plant cells. Such alternative methods include biolistic approaches (Klein et al. (1987) Nat 327, 70) electroporation, chemically-induced DNA uptake, and use of viruses or pollen as vectors.
When necessary for the transformation method, the chimeric genes of the present invention can be inserted into a plant transformation vector, e.g. the binary vector described by Bevan (1984). Plant transformation vectors can be derived by modifying the natural gene transfer system of Agrobacterium tumefaciens. The natural system comprises large Ti (tumor-inducing)-plasmids containing a large segment, known as T-DNA, which is transferred to transformed plants. Another segment of the Ti plasmid, the vir region, is responsible for T-DNA transfer. The T-DNA region is bordered by terminal repeats. In the modified binary vectors the tumor-inducing genes have been deleted and the functions of the vir region are utilized to transfer foreign DNA bordered by the T-DNA border sequences. The T-region also contains a selectable marker for antibiotic resistance, and a multiple cloning site for inserting sequences for transfer. Such engineered strains are known as "disarmed" A. tumefaciens strains, and allow the efficient transformation of sequences bordered by the T-region into the nuclear genomes of plants.
Surface-sterilized leaf disks are inoculated with the "disarmed" foreign DNA-containing A. tumefaciens, cultured for two days, and then transferred to antibiotic-containing medium. Transformed shoots are selected after rooting in medium containing the appropriate antibiotic, and transferred to soil. Transgenic plants are self-pollinated and seeds from these plants are collected and grown on antibiotic-containing medium.
Expression of a heterologous or reporter gene in developing seeds, young seedlings and mature plants can be monitored by immunological, histochemical or activity assays.
As discussed herein, the choice of an assay for expression of the chimeric gene depends upon the nature of the heterologous coding region. For example, Northern analysis can be used to assess transcription if appropriate nucleotide probes are available. If antibodies to the polypeptide encoded by the heterologous gene are available, Western analysis and immunohistochemical localization can be used to assess the production and localization of the polypeptide. Depending upon the heterologous gene, appropriate biochemical assays can be used. For example, acetyltransferases are detected by measuring acetylation of a standard substrate. The expression of an herbicide-resistance gene can be detected by determining the herbicide resistance of the transgenic plant.
Another aspect of the present invention provides transgenic plants or progeny of these plants containing the chimeric genes of the invention. Both monocotyledenous and dicotyledenous plants are contemplated. Plant cells are transformed with the chimeric genes by any of the plant transformation methods described above. The transformed plant cell, usually in a callus culture or leaf disk, is regenerated into a complete transgenic plant by methods well-known to one of ordinary skill in the art (e.g. Horsch et al. (1985) Science 227, 1129). In a preferred embodiment, the transgenic plant is cotton, oil seed rape, maize, tobacco, or soybean. Since progeny of transformed plants inherit the chimeric genes, seeds or cuttings from transformed plants are used to maintain the transgenic plant line. The instant invention also provides a method for producing a plant with improved seed lipid quality. This method comprises transforming a plant cell with a vector containing a chimeric gene comprising a seed-specific regulatory element linked to the coding sequence of a lipid metabolism enzyme such as a desaturase, and selecting for a plant with the desired characteristics. In a preferred embodiment the regulatory element is provided by nucleotides 1 to 2401 or 851 to 2401 of the URE of HaG3A as shown in SEQ ID NO: 1. The transformed plant cells are regenerated into plants with improved seed lipid quality.
Another aspect of the present invention provides a method for producing a plant with improved seed protein quality. This method comprises transforming a plant cell with a vector containing a chimeric gene comprising a seed-specific regulatory element linked to the coding sequence of a seed storage protein with a high content of lysine and/or methionine residues, and selecting for a plant with the desired characteristic. In a preferred embodiment the regulatory element is provided by nucleotides 1 to 2401 or 851 to 2401 of the URE of HaG3-A as shown in SEQ ID NO: 1. The transformed plant cells are regenerated into plants with improved seed protein quality.
Another aspect of the present invention provides a method for producing a herbicide-resistant plant. Plant cells are transformed with a vector containing a chimeric gene comprising a root-specific regulatory element linked to the coding sequence of a herbicide resistance gene such as a glyphosate resistance gene and then plants with the desired herbicide resistance are selected. Selected plants are those which survive a herbicide treatment which kills untransformed plants of the same kind under the same conditions. In a preferred embodiment, the regulatory element is provided by nucleotides 1 to 1639 or 851 to 1639 of the URE of HaG3-A as shown in SEQ ID NO: 1, and the heterologous sequence is provided by a gene encoding EPSP synthase, acetolactase synthase, or acetohydroxy acid synthase. The transformed plant cells are regenerated into herbicide-resistant plants. In a preferred embodiment, plants are transformed by the vector pRPA-ML-803, which contains the root-specific regulatory element comprising nucleotides 851 to 1639 of HaG3-A and the aroA herbicide-resistance gene.
The following examples further illustrate the invention.
EXAMPLE 1
General Methods
The nucleotide sequences referred to in the following examples are numbered according to Fig. 1-3.
GUS Reporter Gene Constructions
The general purpose GUS reporter cassettes used throughout the examples have been described previously (Jefferson et al. (1987) EMBO J. 6, 3901). Briefly, the coding region of GUS was ligated 5' of the nopaline synthase polyadenylation site in the polylinker site of the A. tumefaciens-derived vector pBIN19 (Bevan (1984) Nucleic Acids Res. 12, 8711). The vector pBIN19 contains the left and right borders of T-DNA necessary for plant transformation, and a kanamycin resistance gene. The resulting construction, pBI101.1, is depicted in Figure 4. Unique restriction sites upstream of the AUG initiation codon of GUS allow the insertion of promoter DNA fragments.
The CaMV 35S promoter was ligated into the HindIII and BamHI sites of pBI101.1 to create pBI121.1, depicted in Fig. 4. To create pBI120, the CaMV 35S promoter was truncated at an EcoRV site at -90 (leaving the CAAT and TATA boxes) and cloned into the polylinker site of pBI101.1.
Table 1 describes the parental plasmids and derivative constructions. HaG3-A-FL and the control constructions pBI121.1 and pBI101.1 are depicted in Figure 4. Figure 5 shows the restriction fragments of genomic clones HaG3-A and HaG3-D used to construct parental plasmids. Figure 6 shows the derivative constructions schematically in relation to the full length construction.
The HaG3-A/GUS constructions represent large overlapping fragments that span the full length regulatory region (-2377 to +24 of Fig. 1). The 3' ends of several constructions were derived from exonuclease III digestions of 2.8 kb HaG3-A fragment in pBluescript (Stratagene) [pHaG3-A- 2.8 (BamHI-PstI), Table 1]. These deletions are shown at the top of Figure 4. The first deletion, pHaG3-A-2.4, contains the HaG3-A CAAT and TATA boxes with its 3' end at -75. Fragments that cont ed the HaG3-A CAAT and TATA boxes were ligated in forward orientation into the promoterless GUS cassette pBI101.1. Fragments that did not contain the HaG3-A TATA box were ligated in both orientations upstream of the truncated CaMV 35S promoter of pBI120. These fragments were subcloned into the appropriate GUS cassette. Constructions are named according to their end sites followed by an F, indicating forward orientation; R, indicating reverse orientation. Arrows indicate the orientation of the fragment with respect to the GUS coding region (Fig. 4). The HaG3-D/GUS constructions contain a 404 bp fragment (Sall-Hpal) in both orientations: Normal (N) and Inverse (I). The accuracy and orientation of each construction was confirmed by double-stranded dideoxy sequencing (Chen and Seeburg, 1985) using primers to regions in the GUS cassettes (Advanced DNA Technologies Lab, Texas A&M University).
Plant Transformation
The BIN-19 based plasmid constructions were used to transform tobacco (Nicotiana tabacum cv. Xanthi) according to standard procedures (Horsch et al. 1985) except that initial transformants were selected on 50 μg kanamycin/ml and then were transferred to 100 μg/ml kanamycin. Plants were self-pollinated, and seeds were germinated on kanamycin (400 g/ml) to identify transformants, since the BIN-19 based constructions contain the neomycin phosphotransferase gene (NPTII), which confers resistance to the toxic antibiotic kanamycin. The copy number of each GUS construction integrated into the tobacco genome was estimated for each transforraant by segregation frequencies of the NPTII gene. Most of the transformants contained only one segregating locus of the construction. Filial, homozygous plants were used where indicated. Transgenic plants respresenting all of the test constructions were obtained except for the reverse construction of H- 2. Transgenic plants were maintained in Conviron chambers: 16h light: 8h dark, 24°C, 70-80% relative humidity. All plants were watered on a strict schedule to prevent desiccation prior to testing.
TABLE 1
Construction Description
Parental Plasmids
pBI101.1 Bin 19-derived promoterless GUS reporter gene cassette.
PBI121.1 CaMV 35S promoter fused to GUS cassette in pBI
101.1.
pBI120 CaMV 35S promoter truncated at EcoRV site,
leaving CAAT and TATA boxes, fused to GUS coding region.
pHaG3-A-2.8 2.8 kb BamlH-PstI fragment of Hag3-A in
pBluescript; contains 2.4 kb upstream of HaG3-A coding region and 0.38 kb downstream of
transcription start site; used to generate exonuclease III deletions.
pHaG3-A-2.4 2.4 kb HaG3-A fragment generated from 3'
exonuclease III digestion of pHaG3A-2.8 to +24, contains the HaG3-A CAAT and TATA boxes.
pHaG3-A-2.3 2.3 kb HaG3-A fragment generated from 3'
exonuclease III digestion of pHaG3A-2.8 to -75, contains the HaG3-A CAAT box.
Derivative Constructions
HaG3-A-FL 2.4 kb insert of pHaG3A-2.4 fused to pBI101.1 in forward orientation
HaG3-A-HS/F 0.85 kb BamHl-SalI fragment from pHaG3A-2.3
-HS/R cloned in forward and reverse orientation with respect to the truncated CaMV 35S promoter of pBI120.
HAG3-A-HS/R 0.85 kb excised as a SacI fragment from HaG3A-
HS/F and cloned in reverse orientation with respect to the truncated CaMV 35S promoter pBI 120.
HaG3-A-HB/F 1.6 kb BamHl-BalI fragment from pHaG3A-2.3
-HB/R cloned in forward and reverse orientations with respect to the truncated CaMV 35S promoter pBI 120.
HaG3-A-S 2/F 0.6 kb SalI-Ball from HaG3-A cloned in forward
-S 2/R and reverse orientations with respect to the truncated CaMV 35S promoter of pBI120;
constructed by deleting SalI-BamHl fragment from HaG3-A-HB/F and HaG3-A-HB/R, respectively.
HaG3-A-S 2/F 1.4 kb SalI Iragment from pHaG3-A-2.3 cloned in
-S 2/R forward and reverse orientation with respect to the truncated CaMV 35S promoter in pBI120.
HaG3-A-B 2/F 0.66 kb Ball SalI fragment from pHaG3-A-2.3
-B 2/R cloned in forward and reverse orientation with respect to the truncated CaMV 35S promoter in PBI120.
HaG3-A-H 2 2.3 kb insert from pHaG3-A-2.3 cloned in forward orientation with respect to the truncated CaMV 35S promoter of pBI120.
HaG3-A-S 1 1.5 kb Sall fragment from pHaG3-A-2.4 cloned in forward orientation with respect to pBI 101.1.
HaG3-D-404N 0.4 kb Sall-HpaI fragment form HaG3-D cloned in
-4041 forward and reverse orientation with respect to the truncated CaMV 35S promoter in pBI120. EXAMPLE 2
Biochemical Detection of GUS Activity:
Seed-Specific and Root-Specific Expression
GUS activity was determined in embryonic and non-embryonic tissues of transgenic tobacco containing each construction of Table 1. The standard procedures of Jefferson et al. (1987) were followed.
Plant tissue was ground in extraction buffer (50 mM NaPO4, 10 mM EDTA, 0.1% Sarkosyl, 0.1% Triton X-100 and 10 mM ß-mercaptoethanol). After centrifugation of the lysate, the supernatant was removed to a fresh tube and dispensed in 100 μl aliquots. An equal volume of 2 mM 4-methlumbelliferyl-ß-D-glucuronide in extraction buffer was added and allowed to incubate at 37°C for 1 h. Reactions were stopped with 0.8 ml Na2CO3 (0.2 M). The fluorescence of the resulting 4-methylumbelliferone (4-MU) was determined with a Hoeffer TKO-100 minifluorometer as described (Jefferson et al. 1987). GUS activity is expressed in picomoles 4-MU per unit mass total protein sample per minute.
Cotyledons, hypocotyls, leaves, and roots from transgenic seedlings, ranging from 18 to 20 days post-inbibition (DPI), containing various sequence elements of HaG3-A (summarized in Fig. 4) driving GUS expression were assayed for activity. Results are provided in Table 2. All constructions containing some portion of the URE of the helianthinin genes HaG3-A and HaG3-D conferred GUS activity in transgenic tobacco seeds. The full length regulatory region (FL) and fragments derived from this region, as well as the HaG3-D/GUS constructions, all conferred significant GUS activity in mature seeds when compared with the GUS expression driven by the intact CaMV 35S promoter complex (pBI121). However, well-defined seed-specific expression was only obtained with constructs including the proximal upstream regions between -75 and +24 (cf. FL and S- 1). These two constructions containing nucleotides -2377 to +24 or -1527 to +24 demonstrated tissue-specific GUS expression with no detectable GUS activity in any tissues of transgenic seedlings. The FL construct, however, was expressed in mature seeds at sixfold higher levels compared to S- 1. GUS activity in tissues of seedlings containing the intact CaMV 35S promoter complex (pBI121) are included for comparison as well as the negative controls containing the truncated CaMV 35S promoter (pBI120) or no promoter (pBHOl). Compared to expression in seeds there was little expression in leaves containing the same construction; on the other hand, most constructions, other than FL and S- 1, demonstrated significant expression in roots of transgenic seedlings.
The overall activity conferred by the intact CaMV 35S promoter complex was higher than that conferred by all other constructions in somatic tissue except in roots. In particular, roots of seedlings containing the HB/R (-2377 to -739) and SB/R (-1527 to -739) constructions showed levels of GUS activity 7 to 8 times above that of roots expressing GUS under control of the intact CaMV 35S promoter.
TABLE 2
Summary of GUS Expression in Embryonic and
Non-Embrvonic Tissues of Transgenic Tobacco
CONSTRUCTION DEVELOPMENTAL GUS ACTIVITY (pmole 4MU/μg/min)++ ABA
PROFILEc SEEDSa LEAFd ROOT Response
HaG3-A
FL I 18.7±8.7 0 0
S- 1 I 3.4±1.1 0 0 ND
F III 17.1±15 0 .45±0.05 36.6±2.2 -
HS
R NDa 6.2±1.0 0 .23±0.05 8.9+1.8 -
F II 14.8±5.2 0 .95±0.13 29.9±2.2 +
HB
R ND 13.1+6.9 0 .25±0.05 75.4+3 -
F II 11.1±5.8 0 13.9±6.8 -
SB
R ND 12.1+5.8 0 .34±0.05 90.5±9.9 +
F II 35.7±4.2 0 20.6±10.2 ND
S- 2
R ND 21.0±15 0 .45±0.08 38.8±1.2 +
F III 11.2±3.9 2 .03±0.08 8.0±0.62 +
B- 2
R ND 7.2±2.3 4 .05±0.10 3.9+0.3 +
H- 2 F III 1.8±1.0 ND 1.8±0.3 ND
HaG3-D
N III 9.2±2.9 0.07±0.01 6.8±0.5 +
404
I ND 9.2±3.9 2.03±0.05 12.9±2.8 +
Controls
pBI 101 ND 0 0 0 - pBI 120 ND 0 0 0 - pBI 121 ND 4.3+1.0 22.0+7.9 9.9+4.0 - TABLE 2 (continued)
a Mature seeds and seedling tissues of transgenic tobacco containing constructions in Fig. 1 were assayed for GUS activity.
b Constructions are as shown in Fig. 1. Forward (F) and
Reverse (R), Normal (N) and Inverted (I), refer to the orientation of each helianthinin fragment with respect to the truncated 35S CaMV promoter.
c Developing seeds of transgenic tobacco containing forward constructions in Fig. 1 were assayed for GUS activity at approximtely 2 days intervals from 8-24 DPF. Type I, II and III profiles are defined in Example 3.
d ND, not determined in this experimental series.
e In all experiments, GUS assays represent averages from four to ten independently transformed plants for each construc- tion. Standard deviations are included.
f GUS activity in mature (30 DPF) transgenic tobacco seeds. g Transgenic tobacco seedlings were grown axenically on solid medium. Tissues from seedlings (18-20 DPI) were collected and assayed for GUS activity.
FL ABA responsive only in developing seeds 12-18 DPF (see text and Table 3). All others, ABA response predicted from GUS expression of dessicated leaves and subsequent
demonstration that seedlings of indicated plants respond directly to exogenous ABA. 'Plus sign indicates induction of GUS activity over basal level. Minus sign indicates no detectable induction of GUS activity.
EXAMPLE 3
Biochemical Detection of GUS Activity:
Temporally-Regulated Expression The temporal profile conferred by each forward const ion was determined and the results are shown in Table 2. Filial homozygous plants were grown and allowed to flower, and seeds from staged pods were assayed for GUS expression as described in Example 2. Three types of developmental profiles were identified based on the time of initial appearance of GUS activity in developing embryos and the qualitative and quantitative characteristics of the resulting expression patterns; Type I profiles showed correct temporal regulation where accumulation of GUS begins 12 DPF. In plants exhibiting Type II profiles, GUS activity also began accumulating around 12 DPF but peaked around 14 DPF followed by significant declines in levels of GUS activity. Type III plants showed activity occurring before 10 DPF with a peak of activity occurring at approximately 12 DPF. Constructions containing the regions of the HaG3-A URE from nucleotides -2377 to -1527 or -739 to -75 conferred this temporally earlier profile.
EXAMPLE 4
Histochemical Localization of GUS Activity
GUS activity was histochemically localized in seedlings containing HaG3-A-SB/R and HaG3-D-404N. Samples were washed in 50 mM NaPO4 and incubated for 24 h at 37°C in 100μl reaction buffer [50 mM NaPO4, pH 7.0, 2 mM 5-bromo-4-chloro-3- indolyl-glucuronide (X-Gluc), 0.1 mM potassium ferricyanide, and 0.1 mM potassium ferricyanide, and 0.1 mM potassium ferrocyanide]. Samples were mounted on microscope slides with 80% glycerol.
HaG3-D-404N (Fig. 7A) and HaG3-A-SB/R (Fig. 7B) seedlings grown on basal media containing 1% sucrose showed slightly different patterns of expression. HaG3-D-N driven GUS expression appeared at low levels in the cotyledons and at sifnificantly higher levels in the distal root region with no detectable activity in the hypocotyl. The HaG3-A-SB/R seedling also showed significant GUS activity in the distal root with no detectable activity in the hypocotyl or cotyledons. GUS activity was histochemically localized at 14 DPI in seedlings containing HaG3-D-404N that were grown in a water-deficient environment on sub-saturated filter paper; GUS activity was primarily in the leaves and roots of these seedlings (Fig. 7C).
The GUS expression patterns of seedlings containing HaG3-A-SB/R was determined. The major site of GUS activity in the SB/R seedling was in the developing root tips (Fig. 7B, C). In 6 DPI seedlings containing HaG3-A-SB/R, GUS was expressed throughout the length of the elongating root with particularly high levels in the meristematic region of the root tip (Fig. 7D). Histochemical localization of HaG3-A-SB/R seedlings (14 DPI) showed activity in newly formed lateral roots as well as the continued activity in the meristematic region of the main root (Fig. 7B). Seedlings from 16 DPI continued to show this pattern of expression (Fig. 7C); root hairs and the distal portions of the root had high levels of GUS activity as well.
EXAMPLE 5
ABA-Responsive Expression
In a series of whole plant experiments on transgenic tobacco containing constructions illustrated in Fig. 4, several regions of the UREs of HaG3-A and HaG3-D were identified that responded to changes in the plants water potential (Table 2). Since ABA is a known mediator of water-deficit responses, the effect of ABA on GUS expression driven by these elements was determined. Within HaG3-A, two regions (-1527 to -739 and -739 to -75) were shown to confer ABA-responsive expression in leaves of mature transgenic tobacco and in seedlings. Another ABA-responsive element was identified in the URE of HaG3-D (-739 to -322).
The induction of GUS activity in transgenic tobacco containing HaG3-D-404N (forward orientation) was correlated with water potential during processive desiccation and subsequent recovery from water deficit. Since the full length HaG3-A URE is not expressed under any conditions except during seed development, plants containing this chimeric GUS construction were used as negative controls. Filial, homozygous plants containing each construction were grown in soil. Plants were either watered normally (control) or stressed to varying degrees by watering with 1/3 the amount of the control plant or by not watering at all. Fully stressed plants containing HaG3-D-404N were induced rapidly with a peak of GUS activity at about 36 hours, which correlated with a decrease in water potential (Fig. 8). Subsequent GUS determinations 24 hours later revealed a reproducible decrease in GUS activity even though the plants were under severe water-deficit with water potential of nearly -4 bars. The fully stressed plants were recovered by watering after sampling was completed on day 3. The plants recovered quickly as the water potential returned to non-stressed levels after watering, and GUS activity continued to decrease over the remaining days. GUS activity in 1/3 stressed plants containing HaG3-D-N increased more moderately during a 3.5 day interval as the water potential decreased (Fig. 8). As observed with fully stressed plants, GUS activity decreased before water-deficit recovery. In no instance did the FL plants express GUS in non-embryonic tissues.
To determine if the 404 bp fragment from HaG3-D responds directly to ABA, leaf disks of transgenic tobacco containing HaG3-D-404N were treated with ABA for increasing periods of time and were subsequently assayed for GUS expression. After a lag-time of approximately 3.5 hours, treatment with 10 mM ABA resulted in a rapid increase in GUS expression; GUS continued to accumulate through eight hours at which time the rate of accumulation decreased significantly (Fig. 9). There was no detectable GUS activity in leaf disks from the same plant maintained under identical conditions exclusive of ABA. Likewise, leaf disks from plants containing the HaG3-A full length URE showed no activity during the course of the experiment. Since the chimeric gene including the CaMV35S promoter and the ß-glucuronidase reporter gene is transcriptionally active in leaves (Table 1), transgenic plants containing pBI121 served as an important negative control. Leaf disks from plants containing pBI121 showed no increase in GUS activity in response to exogenous ABA throughout the experiment (+ABA: 12.6±3.3 pmole 4-MU/μg/min; -ABA: 13.5±3.6 pmole 4-MU/μg/min).
A similar series of experiments was carried out with transgenic tobacco seedlings containing HaG3-D-404N and HaG3-A-FL (Fig. 4). Eighteen DPI seedlings were transferred to media containing 0-10 mM ABA, and GUS activity was determined one, two and three days later (Table 3). Seedlings containing HaG3-D- 404N were inducible by ABA by day 1 at all ABA concentrations; there was no significant induction of HaG3-A-FL in parallel experiments. Induction was concentration and time dependent. Maximum induction, exceeding 200 fold, occurred at two and three days at ABA concentrations of 10 mM (Table 3). Significant induction of 19 and 70 fold occurred on day three at 0.1 mM and 1.0 mM ABA, respectively.
The full-length (FL) helianthinin HaG3-A URE (-2377 to +24) was tested for its inducibility by ABA in developing seeds. Seeds containing the full length (FL) regulatory region driving the expression of GUS (Fig. 4) were staged at 11, 14, 18 and 24 days post flowering and were tested for their ability to respond to ABA. Induction by ABA was shown by the increased levels of GUS activity over levels obtained on basal media; results are summarized in Table 3. ABA responsiveness varied with the stage of development. Seeds from 11 DPF did not respond to ABA during the course of the experiment whereas more mature seeds did respond. Seeds from 14 DPF responded rapidly with induction above basal levels beginning as early as 1.5 hours. There was a monotonic increase in GUS activity with 14 DPF seeds treated with ABA; by three days of treatment, the levels of GUS activity were higher than that for 18 and 24 DPF seeds treated with or without ABA. Seeds from 18 DPF were slower to respond to ABA than those from 14 DPF, but levels of GUS activity comparable to 14 DPF (+ABA) seeds were observed in 18 DPF seeds by the fifth day of ABA treatment. Seeds from 24 DPF are less responsive to ABA through five days of ABA treatment. Levels of GUS activity also varied with seeds incubated on basal media alone. Seeds from 14 DPF on basal media continued to increase in GUS activity an estimated 4 pmol 4-MU/seed/day.
The preceeding results demonstrate a hierarchy controlling helianthinin gene expression so that the ABA-responsive elements contained within the HaG3 UREs are functional only within the context of the appropriate developmental program, i.e. seed maturation. Taking the ABA-responsive elements out of the context of the HaG3-A or HaG3-D UREs results in the loss of hierarchical control so that these elements are free to respond directly to ABA and indirectly to desiccation in leaves and seedlings of transgenic tobacco.
Figure imgf000040_0001
EXAMPLE 6
Introduction of Herbicide Tolerance into Tobacco
The 0.66 kb BalI-SalI fragment from the parental plasmid pHaG3-A-2.3 (Table 1) was linked at its 5' end to a HindIII site and at its 3' end to an EcoRI site. The resulting cassette substituted for the double CaMV promoter region in the pRPA-BL-410 construct (described in French Patent Appln. No. 91 02872, filed March 5, 1991) by digesting pRPA-BL-410 with HindIII and EcoRl and subcloning the cassette into that vector. The resulting construct, termed pRPA-ML-803, comprises in the transcriptional frame the following elements: the helianthinin regulatory element, optimized transit peptide (OTP), aroA gene, nos terminator.
The plasmid pRPA-ML-803 was transferred into
Agrobacterium tumefaciens strain EHA101 (Hood et al. (1986) J.
Bacteriol, 168, 1291) by triparental mating and the resulting
Agrobacterium was used for leaf disk transformation of tobacco.
Regenerated tobacco plants, about twenty centimeters tall, were sprayed in the greenhouse with glyphosate formulated as ROUNDUP at a dose of 0.6Kg of active ingredient/hectare. Untransformed control plants Were killed when sprayed with this dose of glyphosate. Transformed plants, which were healthy and viable, showed enhanced tolerance to glyphosate exposure.
SEQUEMCE LISTING
(1) GENERAL INFORMATION:
(i) APPLICANT: Thomas, Terry
Freyssinet, Georges
Lebrun, Michel
Bogue, Molly
(ii) TITLE OF INVENTION: Chimeric Plant Genes Based on Upstream
Regulatory Elements of Helianthinin
(iii) NUMBER OF SEQUENCES: 3
(iv) CORRESPONDENCE ADDRESS:
(A) ADDRESSEE: Scully, Scott, Murphy & Presser
(B) STREET: 400 Garden City Plaza
(C) CITY: Garden City
(D) STATE: New York
(E) COUNTRY: USA
(F) ZIP: 11530
(v) COMPUTER READABLE FORM:
(A) MEDIUM TYPE: Floppy disk
(B) COMPUTER: IBM PC compatible
(C) OPERATING SYSTEM: PC-DOS/MS-DOS
(D) SOFTWARE: PatentIn Release #1.0, Version #1.25
(vi) CURRENT APPLICATION DATA:
(A) APPLICATION NUMBER:
(B) FILING DATE:
(C) CLASSIFICATION:
(viii) ATTORNEY/AGENT INFORMATION:
(A) NAME: McNulty, William E.
(B) REGISTRATION NUMBER: 22,606
(C) REFERENCE/DOCKET NUMBER: 8081
(ix) TELECOMMUNICATION INFORMATION:
(A) TELEPHONE: 516-742-4343
(B) TELEFAX: 516-742-4366
(2) INFORMATION FOR SEQ ID NO: 1:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 2401 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : both
(D) TOPOLOGY: linear (xi) SEQUENCE DESCRIPTION: SEQ ID NO: 1:
GGATCCTCTA CCTATATATA TATATATATA TGAATTTTTT AAAAAAATCC CGTACCCCTC
GAAAAAACGG GCCTTATGCG GAAGTCCTCC TCGCACACCT AAAGAGCCGC CCATGCTTTT
TAATCAAATA GATGTGCATC ATGTAGTGAT AGTTTTTACT AAAATCCATT AGTTTATAAA
TATTTTAAAT GTTTTTTTTT GTTTATATAA AAAAAGAAAA TTAAAAAACA AAATGTCCAA
AATACTCCTG TATCAACTAT GCAAAAAGAC AAAAAAACCC TTTTGGTTAA CAAAGTCTTT
AATTTAACTA AGTTTGTCAT TTGAAGGAAA TTCAAACAAA AACGAACGTG GGGGCGCGGG
GGTGGGGTGT TTGGTTACAA AAAGTTTTAA TTTTAGATTA AAGTATAAAA ATTGCCCAAA
CCTCAGGACA ATTTTTACAT TTATAACTCA TTGTCTAAAT ACTAAAATAC ACCAAGTCAA
TGGGTGAAAG TTACTATCTT TTTTATTGCA ATTTCACATT ACCTTATTTA CTTTTGAGAA
AGACGACATA ACAATTAAGG AGTTATAGTC TGATCGGTTT GCGCTATTTT TCATACTTAA
GGTCCAGGTT TGAATCTTTT AAACATTTTT TTTTAACTTG ATCATAACAA TATAACAATT
AAGGAGTTAT GATCTGATGG TTTGCGTTAT GTTTTCGTAC TAATTAAGGT CCCGGTTTGA
ATCTCTCAAA CAATATATTA TTTTTTCTTA AAAACGAATG AGACATGCTC ACAATGGGAA
TTGAACCGAC ACCTATTGGT TTAAAATTAA AGCTATAACA AACTGAGCTA CACATTTTTA
ATTTAAAAAT GTCGACTATC TTAGTTAATC AAATAAATTT ATTTTGATTT GTTTTGTTAA
TGTATTTTCT CCTAATTTAA AGTCGATGTG TATTTATATA ATATTAGTAA TATTTTATTA
ACATCAATAC ATGCTTCAGG TTTTGTGTTA GTCTTCGTTT TTTATATGGT TTTATCAGTG
GTGTGGTGTA CGATGACGAT TATTTAAATA ATGACGAACT TCTTGGTTGT TACTTATTGA
TGTACGAAGC TGAGATGTAA CGAACCGAAC ACATATAAAT AACATTTTGG ATAAGATTAC
GACTTTATTT ATCGGTTGCC ATGAAATTTA GAAGATTTGG GTTAAGACAC AACCACATAT
AATGTGATGG TAAATAGCAT TTACAACTAA TGTTAATCTT TTGTTACAAA TGTTGTTAAC
TAGGCTTGAT ATGTAAAATT TTTAAAGACT ATCAGGTGTT CTTACGGTTT TACATCTAGT
AAGAGATTAA AAAAAAAAAA GCAAGGAAAG TAAGTGTAAA GAGAGTAAAG AGAATGTAGC
CATGATATGG CTGATTGTTC ATCACCATCC CATTTATACT TATCATCTTG ATGATGCATA
TAGACATGAT GTGTGCTACG TACCGAATTT TAACAGCTTC CCGGCGCAAC ACACGTGTAT
AAATACCATA GATTATAAAC CAAATACGCT ACGTATAGGT GGTTATATGA TACCTATGAT
GACTTGACCT TTCGTTACAC TTGAGCTGAA AAAAATAAAA AAATGTGGCT ATAGGCGCAT GGTCACAGTT TTTTTGTGTG GCCATATACA ATTTTTGACG TAGCGTTAGT TAATCAGATA 1680
AATTTATTTT GATTTGTTTT GTTAATGTAT TTTCTCCTAA TTTCAAGTAG ACGTGTATTT 1740
ATATAATATT AGTAATATTT TATTAACATC AATACATGCT TCATGTTTTG GGTTAGTCTT 1800
CGTTTTTTAT ATGGTTTTAT CAGTGGTGTA CGATGACGAT TATTTAAATA ATGACGGACT 1860
TCTTGGTTGT TACTTATTGA TGTACGAAGC TGAGATGTAA CGAACCGAAC ACATATAAAT 1920
AACATTTTGG ATAAGATTAC GACTTTATTT ATCGGTTGCC ATGAAATTTG GAAGACTTGG 1980
GTTAAGACAC AACCACATAT AATGTGATGG TAAATAGCAT TTACAACTAA TGTTAATCTT 2040
TTGTTACAAA TGTTGTTAAC TAGGCTTGAT ATGTAAAATT TTTAAAGACT ATATGGTGTT 2100
CTTACGGTTT TACATCTAGT AAGAGATTAA AAAAAAAAAA AAAAGCAAGG AAAGTAAGTG 2160
TAAAGAGAGT AAAGAGAATG TAGCCATGAT ATGGCTGATT GTTCATCACC ATCCCATTTA 2220
TACTTATCAT CTTGATGATG CATATAGACA AACACACTAC TTATACAGAT GTAGCATGTC 2280
TCAGCTCCAA ATGGTGATCT TCTCCTGGCA TAACCTCTTA GATGTCACTT CCTCCTTGAT 2340
CTTCTTCCAC TATAAAACCA GCTAGTTCAC AACACCTATT CACCACATCA CATCCCATTC 2400
C 2401 (2) INFORMATION FOR SEQ ID NO: 2:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 1732 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : both
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 2:
GGATCCTGTA AGAAGTGCCC AAAATGTGAG AAGTGTATTA TAACACTATA TATAATACTA 60
TATAACACCA TATAAATACC GTATAACACT ATGTAACACC ATATAACACA ATATAACGCT 120
ATGTAACACT ATATAACATT ATATAACAAT ATATAACACT ATACATCTAT CAGAGACATG 180
CTATCAGACA ACCTATAGTG TTATATTTGT TATATAATGT TATATAGTGT TACATAGCGT 240
TATATGGTAT TATATGGTGT TACATATTGT TATACGTGTT TATATGGTGT TATATAGTAT 300
TATATATAGT GTTATAATAC ACTTCTCACA CTTTGGGCAC TTTTTACAGG ATCATCTACC 360
TATATATATA TATATATATA TAAAGGATTA GGTTCAAACG TGAACAAATT CCCAAGAGTG 420
AACTGCGTGA ACTGATCTCA GCCCTTGATT TTTATGATCT TGAGATTAAA . GTGAGTGGCA 480 TGATGGTAAT TATTTGGTTA ATTTTTTTTC ATTTAATTAA ATACAAAAAG GGTATATGTG 540
TAATTTCAAT CTTAAATTGA TTGCATAAAT CTCTCACAAA TCAAGTAATC AATTATCTTC 600
TTAAACTGAT TACATAAATC TCTCACAAAT CAAATCAAGG ATTAGGAAAG ATGTAACTTA 660
ATTCTAATTA CTAAAATAAC TATTTGTTTA AATGCGATGT ACACATGTGT ATTCTGATTT 720
TGCCCTCTTT TTAATGTGAT GTACACATGT GTATATCGTC TGTTTTTATG AGATCTCAGA 780
ATTTTTTTTG TATTGAATGT TGATGTACAC CTGTGAATTA CTGTACACAT ATGTACGATG 840
CTGATGCTGA GTACACATGT GTACTGTTCT ATTTATATCC AAGTACACAT GTGTAACCTT 900
GAAATATGAA AGTTACGTGG ATCTTAAAAA TCAAAATTTG AATTCTGGTG ATGAAATCTG 960
AAATAAAAAT TAAAATTGAA ATCTGGTGAT TTGTTGTTTG TTTTGATAAT TATCTTATTA 1020
ATAAATAAAC ATAATGTGGA TAATGAATTT AAATTAGGAA AGATGTAACT TAATTCAATT 1080
ATTAAAATAA TGATTTAAAT CTAATTTTTT ATATAATTAC AATCCTACCC TTAACAACTA 1140
AAAAGGAAAT CAAGGGTTCA TATCTGTTCA CGCAGTTCAC TCTTGGGAGG TTGTTCACGC 1200
TGGAACCCTA CCCTATATAT ATATATATAT ATATATCAAA TTTTTTTAAA AAATCCCGTA 1260
CCCCTCGAAA AAACGGGCCT TATGCGGAAG TCCTCCTCGC ACACCTAAAG AGCCGCCCAT 1320
GCTTTTGATC AAATAGTTGT AAATACTAAA ATACACCAAG TCAATGGGTG AAAGTTACTA 1380
TCTTTTTTAT TGCAATTTCA CATTACCTTA TTTACTTTTG AGAAAGACGA CATAACAATT 1440
AAGGAGTTAT AGTCTGATCG TTTGCGCTAT TTTTCATACT TAAGGTCCAG GTTTGAATAT 1500
TTTAAACATT TTTTTTAACT TGATCATAAC AATATAACAA TTAAGGAGTT ATGGTCTGAT 1560
GGTTTGCGTT ATGTTTTCGT ACTAATTAAG GTCCCGGTTT GAATCTCTCA AACAATATAT 1620
TATTTTTACC TAAAAACGAA TGAGGCATGC TCACAATGGG AATTGAACCG ACACCTATTG 1680
GTTTAAAATT AAAGCTATAA CAAACTGAGC TACACATTTT TAATTTAAAA AT 1732 (2) INFORMATION FOR SEQ ID NO: 3:
(i) SEQUENCE CHARACTERISTICS:
(A) LENGTH: 404 base pairs
(B) TYPE: nucleic acid
(C) STRANDEDNESS : both
(D) TOPOLOGY: linear
(xi) SEQUENCE DESCRIPTION: SEQ ID NO: 3:
GTCGACTATC TTAGTTAATC AAATAAATTT ATTTTGATTT GTTTTGTTAA TGTATTTTCT 60 CCTAGTTTAA AGTCGATGTG TATTTATATA ATATTAGTAA TATTTTATTA ACATCAATAC 120
ATGCTTCAGG TTTTGTGTTA GTCTTCGTTT TTTATATGGT TTTATCAGCG GTGTGGTGTA 180
CGATGACGAT TATTTAAATA ATGACGGACT TCTTGGTTGT TACTTATTGA TGTACGAAG2 240
TGAGATGTAA CGAACCGAAC ACATATAAAT AACATTTTGG ATAAGATTAC GACTTTATTT 300
ATCGGTTGCC ATGAAATTTG GAAGACTTGG GTTAAGACAC AACCACATAT AATGTGATGG 360
TAAATAGCAT TTACAACTAA TGTTAATCTT TTGTTACAAA TGTT 404

Claims

WHAT IS CLAIMED:
1. An isolated nucleic acid from a helianthinin gene comprising at least one regulatory element which directs at least one of seed-specific gene expression, root-specific gene expression, abscisic acid (ABA)-responsive gene expression and temporally-altered gene expression.
2. The nucleic acid of Claim 1 wherein said helianthinin gene is selected from an Ha2 gene, an Ha10 gene, an HaG3A gene or an HaG3D gene.
3. The nucleic acid of Claim 1 wherein said regulatory element is selected from an Ha2 gene, an Ha10 gene, an HaG3A gene or an HaG3D gene.
4. The nucleic acid of Claim 1, 2 or 3 wherein the regulatory element which directs seed-specific gene expression is characterized in that expression of a gene under its control is detectable in seeds.
5. The nucleic acid of Claim 1, 2 or 3 wherein the regulatory element which directs root-specific gene expression is characterized in that expression of a gene under its control is detectable in plant roots.
6. The nucleic acid of Claim 1, 2 or 3 wherein the regulatory element which directs ABA-responsive gene expression is characterized in that expression of a gene under its control is detectable in response to treatment with ABA or conditions which induce ABA biosynthesis.
7. The nucleic acid of Claim 1, 2 or 3 wherein the regulatory element which directs temporally-altered gene expression is characterized in that expression of a gene under its control is detectable in plant seeds as early as 4 days post-flowering.
8. The nucleic acid of Claim 1 or 4 wherein said regulatory element directs seed-specific gene expression and comprises nucleotides 1 to 2401 or 851 to 2401 of SEQ ID NO: 1.
9. The nucleic acid of Claim 1 or 5 wherein said regulatory element directs root-specific gene expression and comprises nucleotides 1 to 1639 or 851 to 1639 of SEQ ID NO: 1.
10. The nucleic acid of Claim 1 or 6 wherein said regulatory element directs ABA-responsive gene expression and comprises nucleotides 1 to 2401 of SEQ ID NO: 1, nucleotides 851 to 1639 of SEQ ID NO: 1, nucleotides 1639 to 2303 of SEQ ID NO: 1 or nucleotides 1 to 404 of SEQ ID NO: 3.
11. The nucleic acid of Claim 1 or 7 wherein said regulatory element directs temporally-altered gene expression and comprises nucleotides 1 to 851 or 1639 to 2303 of SEQ ID NO: 1.
12. The regulatory of any one of Claims 1-11 wherein said regulatory element is operably linked to the coding sequence of a heterologous gene to effect said expression of a gene product from said coding sequence and to provide a chimeric plant gene.
13. The chimeric plant gene of Claim 12 comprising a sufficient part of a promoter capable of functioning in plants and operably linked to said coding sequence and said regulatory element to effect expression of said heterologous gene.
14. The chimeric plant gene of Claim 25 wherein said promoter is a plant virus promoter or the cauliflower mosaic virus (CaMV) 35S promoter.
15. The chimeric plant gene of Claim 14 wherein said promoter is the CaMV 35S promoter comprising CAAT and TATA sequences.
16. The chimeric plant gene of Claim 12 wherein said heterologous gene is a gene encoding a lipid metabolism enzyme, a desaturase, a herbicide resistance gene, a glyphosate resistance gene or a gene encoding 5' enolpyruvylshikimic acid-3-phosphate synthase, acetolactase synthase, or acetohydroxy acid synthase.
17. The chimeric gene of Claim 16 wherein said glyphosate resistance gene is aroA.
8. The chimeric gene of Claim 17 which comprises the chimeri ant gene of pRPA-ML-803.
19. A plant transformation vector which comprises the chimeric plant gene of any one of Claims 12-18.
20. A plant cell comprising the transformation vector of Claim 19.
21. A plant, or a progeny of said plant, which has been regenerated from the plant cell of Claim 20.
22. The plant of Claim 21 wherein said plant is a cotton, tobacco, oil seed rape, maize or soybean plant.
23. The plant cell of Claim 20 wherein said plant cell is a cotton, tobacco, oil seed rape, maize or soybean plant cell.
24. A method for producing a plant with improved seed lipid quality which comprises:
a) transforming a plant cell with the transformation vector of Claim 19; and
b) regenerating said plant with improved seed lipid quality from said transformed plant cell.
25. A method for producing a plant which exhibits resistance to a herbicide which comprises:
a) transforming a plant cell with the transformation vector of Claim 19; and
b) regenerating said plant from said transformed plant cell.
26. The use of regulatory element of any one of Claims 1-12 for producing transgenic plants.
27. The use of the nucleic acid of any one of Claims1-11 for producing transgenic plants.
PCT/US1992/002822 1991-04-08 1992-04-07 Chimeric plant genes based on upstream regulatory elements of helianthinin WO1992017580A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1019930703055A KR100228918B1 (en) 1991-04-08 1992-04-07 Chimeric plant genes based on upstream regulatory elements of helianthin
JP4509101A JPH06509939A (en) 1991-04-08 1992-04-07 Chimeric plant gene based on upstream regulatory elements of heliantinin
AU16819/92A AU672949B2 (en) 1991-04-08 1992-04-07 Chimeric plant genes based on upstream regulatory elements of helianthinin
BR9205873A BR9205873A (en) 1991-04-08 1992-04-07 Nucleic acid isolated from a heliantinin gene, plant chimeric gene regulatory element, plant transformation vector, plant cell, plant, process to produce a plant with improved seed lipid quality, process to produce a plant that is resistant to a herbicide, use of regulatory element and use of nucleic acid
CA002107583A CA2107583A1 (en) 1991-04-08 1992-04-07 Chimeric plant genes based on upstream regulatory elements of helianthinin
UA93003973A UA44217C2 (en) 1991-04-08 1992-07-04 Isolated nucleic acid molecule (optional), fancy vegetable gene (variant), transforming plants vector (option), plant cells (Option) METHOD FOR PRODUCING plants that exhibit herbicide (optional)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68235491A 1991-04-08 1991-04-08
US682,354 1991-04-08

Publications (1)

Publication Number Publication Date
WO1992017580A1 true WO1992017580A1 (en) 1992-10-15

Family

ID=24739323

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1992/002822 WO1992017580A1 (en) 1991-04-08 1992-04-07 Chimeric plant genes based on upstream regulatory elements of helianthinin

Country Status (13)

Country Link
US (2) US5859325A (en)
EP (1) EP0579726A4 (en)
JP (1) JPH06509939A (en)
KR (1) KR100228918B1 (en)
AU (1) AU672949B2 (en)
BR (1) BR9205873A (en)
CA (1) CA2107583A1 (en)
IE (1) IE921108A1 (en)
IL (1) IL101508A0 (en)
MX (1) MX9201592A (en)
UA (1) UA44217C2 (en)
WO (1) WO1992017580A1 (en)
ZA (1) ZA922542B (en)

Cited By (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1997026365A2 (en) * 1996-01-19 1997-07-24 Dekalb Genetics Corporation Transgenic maize with increased mannitol content
WO1998008962A1 (en) * 1996-08-30 1998-03-05 Monsanto Company Early seed 5' regulatory sequence
WO1998045460A1 (en) * 1997-04-09 1998-10-15 Rhone-Poulenc Agro A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
WO1999002688A1 (en) * 1997-07-12 1999-01-21 Societe Des Produits Nestle S.A. Coffee storage proteins
WO2001027298A2 (en) * 1999-10-14 2001-04-19 Pioneer Hi-Bred International, Inc. Sclerotinia-inducible genes and promoters and their uses
WO2002036787A2 (en) 2000-10-30 2002-05-10 Bayer Cropscience S.A. Herbicide-tolerant plants through bypassing metabolic pathway
US6677503B1 (en) 1999-06-23 2004-01-13 Pioneer Hi-Bred International, Inc. Sunflower anti-pathogene proteins and genes and their uses
WO2004053134A1 (en) 2002-12-12 2004-06-24 Bayer Cropscience S.A. Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicide-tolerant plants containing it
US7144569B1 (en) 1999-10-01 2006-12-05 Isis Innovation Limited Diagnosis of coeliac disease using a gliadin epitope
US7288403B2 (en) 1993-08-25 2007-10-30 Anderson Paul C Anthranilate synthase gene and method for increasing tryptophan production
EP2292649A2 (en) 2002-06-05 2011-03-09 ISIS Innovation Limited Therapeutic epitopes and uses thereof
WO2011076892A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076877A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076885A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076889A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076882A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011095460A1 (en) 2010-02-02 2011-08-11 Bayer Cropscience Ag Soybean transformation using hppd inhibitors as selection agents
EP2412380A1 (en) 2004-04-28 2012-02-01 BTG International Limited Epitopes related to coeliac disease
EP2453012A1 (en) 2010-11-10 2012-05-16 Bayer CropScience AG HPPD variants and methods of use
WO2012130684A1 (en) 2011-03-25 2012-10-04 Bayer Cropscience Ag Use of n-(1,2,5-oxadiazol-3-yl)benzamides for controlling unwanted plants in areas of transgenic crop plants being tolerant to hppd inhibitor herbicides
WO2012130685A1 (en) 2011-03-25 2012-10-04 Bayer Cropscience Ag Use of n-(tetrazol-4-yl)- or n-(triazol-3-yl)arylcarboxamides or their salts for controlling unwanted plants in areas of transgenic crop plants being tolerant to hppd inhibitor herbicides
WO2013050410A1 (en) 2011-10-04 2013-04-11 Bayer Intellectual Property Gmbh RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
WO2014043435A1 (en) 2012-09-14 2014-03-20 Bayer Cropscience Lp Hppd variants and methods of use
WO2015138394A2 (en) 2014-03-11 2015-09-17 Bayer Cropscience Lp Hppd variants and methods of use
WO2017042259A1 (en) 2015-09-11 2017-03-16 Bayer Cropscience Aktiengesellschaft Hppd variants and methods of use
WO2017184727A1 (en) 2016-04-21 2017-10-26 Bayer Cropscience Lp Tal-effector mediated herbicide tolerance
WO2017205287A1 (en) * 2016-05-24 2017-11-30 Monsanto Technology Llc Plant regulatory elements and uses thereof
EP3269816A1 (en) 2016-07-11 2018-01-17 Kws Saat Se Development of fungal resistant crops by higs (host-induced gene silencing) mediated inhibition of gpi-anchored cell wall protein synthesis
WO2018098214A1 (en) 2016-11-23 2018-05-31 Bayer Cropscience Lp Axmi669 and axmi991 toxin genes and methods for their use
WO2018119336A1 (en) 2016-12-22 2018-06-28 Athenix Corp. Use of cry14 for the control of nematode pests
WO2018136604A1 (en) 2017-01-18 2018-07-26 Bayer Cropscience Lp Bp005 toxin gene and methods for its use
WO2018136611A1 (en) 2017-01-18 2018-07-26 Bayer Cropscience Lp Use of bp005 for the control of plant pathogens
WO2018165091A1 (en) 2017-03-07 2018-09-13 Bayer Cropscience Lp Hppd variants and methods of use
US10093907B2 (en) 2013-09-24 2018-10-09 Basf Se Hetero-transglycosylase and uses thereof
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
US10138490B2 (en) 2002-09-11 2018-11-27 Michel Matringe Transformed plants tolerant to herbicides due to overexpression of prephenate dehydrogenase and p-hydroxyphenylpyruvate dioxygenase
WO2019083808A1 (en) 2017-10-24 2019-05-02 Basf Se Improvement of herbicide tolerance to hppd inhibitors by down-regulation of putative 4-hydroxyphenylpyruvate reductases in soybean
WO2019083810A1 (en) 2017-10-24 2019-05-02 Basf Se Improvement of herbicide tolerance to 4-hydroxyphenylpyruvate dioxygenase (hppd) inhibitors by down-regulation of hppd expression in soybean

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE280224T1 (en) * 1996-05-17 2004-11-15 Pioneer Hi Bred Int PROMOTER ELEMENTS WHICH PROVIDE ROOT PREFERRED GENE EXPRESSION
US7897843B2 (en) 1999-03-23 2011-03-01 Mendel Biotechnology, Inc. Transcriptional regulation of plant biomass and abiotic stress tolerance
US20050086718A1 (en) 1999-03-23 2005-04-21 Mendel Biotechnology, Inc. Plant transcriptional regulators of abiotic stress
EP1950306A1 (en) 1999-11-17 2008-07-30 Mendel Biotechnology, Inc. Environmental stress tolerance genes
EP1229781B1 (en) 1999-11-17 2013-01-02 Mendel Biotechnology, Inc. Seed trait genes
EP2410060A1 (en) 2000-08-22 2012-01-25 Mendel Biotechnology, Inc. Genes for modifying plant traits IV
EP2390256A1 (en) 2001-05-30 2011-11-30 Agrisoma, Inc. Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
US7329798B2 (en) * 2002-06-28 2008-02-12 University Of Guelph Harvest-inducible regulatory elements and methods of using same
WO2004002216A2 (en) 2002-06-28 2004-01-08 University Of Guelph Harvest-inducible genes from alfalfa (medicago sativa) and methods of use thereof
ES2380017T3 (en) 2002-09-18 2012-05-07 Mendel Biotechnology, Inc. Polynucleotides and polypeptides in plants
CA2626592C (en) 2005-10-24 2018-07-17 Evogene Ltd. Methods of increasing abiotic stress tolerance and fertilizer use efficiency of a plant
CA3017478A1 (en) 2007-04-27 2008-11-06 The Regents Of The University Of California Plant co2 sensors, nucleic acids encoding them, and methods for making and using them
US9157091B2 (en) 2011-02-24 2015-10-13 Iowa State University Research Foundation, Inc. Materials and method for modifying a biochemical component in a plant
CA2875236A1 (en) 2012-06-22 2013-12-27 Julian I. Schroeder Compositions and methods for mediating plant stomatal development in response to carbon dioxide and applications for engineering drought tolerance in plants
AU2014211570A1 (en) 2013-01-29 2015-07-23 The University Court Of The University Of Glasgow Methods and means for increasing stress tolerance and biomass in plants
EP3431606A1 (en) 2013-07-01 2019-01-23 Bayer CropScience NV Methods and means for modulating flowering time in monocot plants
WO2016050512A1 (en) 2014-10-03 2016-04-07 Bayer Cropscience Nv Methods and means for increasing stress tolerance and biomass in plants
KR102630802B1 (en) 2015-02-18 2024-01-31 아이오와 스테이트 유니버시티 리서치 파운데이션, 인코퍼레이티드 Modification of the transcriptional repressor binding site within the NF-YC4 promoter for increased protein content and resistance to stress.
US20190225974A1 (en) 2016-09-23 2019-07-25 BASF Agricultural Solutions Seed US LLC Targeted genome optimization in plants
CN108103156A (en) * 2018-02-08 2018-06-01 苏州百源基因技术有限公司 For detecting the specific primer of sunflower DNA and probe and real-time fluorescence quantitative PCR kit

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
EP0255377A2 (en) * 1986-07-31 1988-02-03 Calgene, Inc. Acyl carrier protein- DNA sequence and synthesis

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0218571B1 (en) * 1985-08-07 1993-02-03 Monsanto Company Glyphosate-resistant plants
NZ228320A (en) * 1988-03-29 1991-06-25 Du Pont Nucleic acid promoter fragments of the promoter region homologous to the em gene of wheat, dna constructs therefrom and plants thereof
DE69133261D1 (en) * 1990-03-16 2003-06-26 Calgene Llc Davis DNAS CODING FOR VEGETABLE DESATURASES AND THEIR APPLICATIONS

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4394443A (en) * 1980-12-18 1983-07-19 Yale University Method for cloning genes
EP0255377A2 (en) * 1986-07-31 1988-02-03 Calgene, Inc. Acyl carrier protein- DNA sequence and synthesis

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
Gene, Volume 74, issued 1988, VONDER HAAR et al., "Organization of the sunflower 11S storage protein gene family", pages 433-443, see entire document. *
See also references of EP0579726A4 *
The Journal of Biological Chemistry, Volume 257, No. 20, issued 25 October 1982, McKEON et al., "Purification and characterization of the stearoyl-acyl carrier protein desaturase and the acyl-acyl carrier protein thioesterase from maturing seeds of safflower", pages 12141-12147, see entire document. *
The Journal of Biological Chemistry, Volume 265, No. 33, issued 25 November 1990, STUKEY et al., "The OLE1 gene of Saccharomyces cerevisiae encodes the lambda9 fatty acid desaturase and can be functionally replaced by the rat stearoyl-CoA desaturase gene", pages 20144-20149, see entire document. *
The Plant Cell, Volume 1, issued September 1989, JORDANO et al., "A sunflower helianthinin gene upstream sequence ensemble contains an enhancer and sites of nuclear protein interaction", pages 855-866, see entire document. *
Trends in Biotechnology, Volume 5, issued February 1987, KNAUF, "The application of genetic engineering to oilseed crops", pages 40-47, see entire document. *
Trends in Genetics, Volume 4, No. 1, issued January 1988, WILLMITZER, "The use of transgenic plants to study plant gene expression", pages 13-18, see entire document. *

Cited By (62)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7288403B2 (en) 1993-08-25 2007-10-30 Anderson Paul C Anthranilate synthase gene and method for increasing tryptophan production
WO1997026365A3 (en) * 1996-01-19 1997-09-12 Dekalb Genetic Corp Transgenic maize with increased mannitol content
WO1997026365A2 (en) * 1996-01-19 1997-07-24 Dekalb Genetics Corporation Transgenic maize with increased mannitol content
WO1998008962A1 (en) * 1996-08-30 1998-03-05 Monsanto Company Early seed 5' regulatory sequence
US5981841A (en) * 1996-08-30 1999-11-09 Monsanto Company Early seed 5' regulatory sequence
WO1998045460A1 (en) * 1997-04-09 1998-10-15 Rhone-Poulenc Agro A sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
US5959175A (en) * 1997-04-09 1999-09-28 Thomas; Terry L. Sunflower albumin 5' regulatory region for the modification of plant seed lipid composition
WO1999002688A1 (en) * 1997-07-12 1999-01-21 Societe Des Produits Nestle S.A. Coffee storage proteins
US6677503B1 (en) 1999-06-23 2004-01-13 Pioneer Hi-Bred International, Inc. Sunflower anti-pathogene proteins and genes and their uses
US7144569B1 (en) 1999-10-01 2006-12-05 Isis Innovation Limited Diagnosis of coeliac disease using a gliadin epitope
US8329144B2 (en) 1999-10-01 2012-12-11 Isis Innovation Limited Diagnostic and therapeutic epitope, and transgenic plant
US7888460B2 (en) 1999-10-01 2011-02-15 Isis Innovation Limited Diagnostic and therapeutic epitope, and transgenic plant
US6667427B1 (en) 1999-10-14 2003-12-23 Pioneer Hi-Bred International, Inc. Sclerotinia-inducible promoters and their uses
WO2001027298A3 (en) * 1999-10-14 2002-01-17 Pioneer Hi Bred Int Sclerotinia-inducible genes and promoters and their uses
WO2001027298A2 (en) * 1999-10-14 2001-04-19 Pioneer Hi-Bred International, Inc. Sclerotinia-inducible genes and promoters and their uses
EP2141240A2 (en) 2000-10-30 2010-01-06 Bayer CropScience SA Plants that can tolerate herbicides by bypassing the metabolic route
WO2002036787A2 (en) 2000-10-30 2002-05-10 Bayer Cropscience S.A. Herbicide-tolerant plants through bypassing metabolic pathway
EP2292649A2 (en) 2002-06-05 2011-03-09 ISIS Innovation Limited Therapeutic epitopes and uses thereof
EP2826787A1 (en) 2002-06-05 2015-01-21 ISIS Innovation Limited Therapeutic epitopes and uses thereof
US10053497B2 (en) 2002-06-05 2018-08-21 Oxford University Innovation Limited Therapeutic epitopes and uses thereof
US10138490B2 (en) 2002-09-11 2018-11-27 Michel Matringe Transformed plants tolerant to herbicides due to overexpression of prephenate dehydrogenase and p-hydroxyphenylpyruvate dioxygenase
WO2004053134A1 (en) 2002-12-12 2004-06-24 Bayer Cropscience S.A. Expression cassette encoding a 5-enolpyruvylshikimate-3-phosphate synthase (epsps) and herbicide-tolerant plants containing it
EP2486935A1 (en) 2004-04-28 2012-08-15 BTG International Limited Epitopes related to Coeliac Disease
US10105437B2 (en) 2004-04-28 2018-10-23 Btg International Limited Epitopes related to coeliac disease
EP2412380A1 (en) 2004-04-28 2012-02-01 BTG International Limited Epitopes related to coeliac disease
US9017690B2 (en) 2004-04-28 2015-04-28 Btg International Limited Epitopes related to coeliac disease
EP2486934A1 (en) 2004-04-28 2012-08-15 BTG International Limited Epitopes Related To Coeliac Disease
WO2011076882A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076889A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076885A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076877A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011076892A1 (en) 2009-12-23 2011-06-30 Bayer Cropscience Ag Plants tolerant to hppd inhibitor herbicides
WO2011095460A1 (en) 2010-02-02 2011-08-11 Bayer Cropscience Ag Soybean transformation using hppd inhibitors as selection agents
EP2453012A1 (en) 2010-11-10 2012-05-16 Bayer CropScience AG HPPD variants and methods of use
EP2669369A1 (en) 2010-11-10 2013-12-04 Bayer CropScience AG HPPD variants and methods of use
EP2669371A1 (en) 2010-11-10 2013-12-04 Bayer CropScience AG HPPD variants and methods of use
EP2669373A1 (en) 2010-11-10 2013-12-04 Bayer CropScience AG HPPD variants and methods of use
EP2669370A1 (en) 2010-11-10 2013-12-04 Bayer CropScience AG HPPD variants and methods of use
EP2669372A1 (en) 2010-11-10 2013-12-04 Bayer CropScience AG HPPD variants and methods of use
WO2012130685A1 (en) 2011-03-25 2012-10-04 Bayer Cropscience Ag Use of n-(tetrazol-4-yl)- or n-(triazol-3-yl)arylcarboxamides or their salts for controlling unwanted plants in areas of transgenic crop plants being tolerant to hppd inhibitor herbicides
WO2012130684A1 (en) 2011-03-25 2012-10-04 Bayer Cropscience Ag Use of n-(1,2,5-oxadiazol-3-yl)benzamides for controlling unwanted plants in areas of transgenic crop plants being tolerant to hppd inhibitor herbicides
WO2013050410A1 (en) 2011-10-04 2013-04-11 Bayer Intellectual Property Gmbh RNAi FOR THE CONTROL OF FUNGI AND OOMYCETES BY INHIBITING SACCHAROPINE DEHYDROGENASE GENE
EP3173477A1 (en) 2012-09-14 2017-05-31 Bayer Cropscience LP Hppd variants and methods of use
EP3683307A2 (en) 2012-09-14 2020-07-22 BASF Agricultural Solutions Seed US LLC Hppd variants and methods of use
WO2014043435A1 (en) 2012-09-14 2014-03-20 Bayer Cropscience Lp Hppd variants and methods of use
US10093907B2 (en) 2013-09-24 2018-10-09 Basf Se Hetero-transglycosylase and uses thereof
US10647965B2 (en) 2013-09-24 2020-05-12 Basf Se Hetero-transglycosylase and uses thereof
WO2015138394A2 (en) 2014-03-11 2015-09-17 Bayer Cropscience Lp Hppd variants and methods of use
WO2017042259A1 (en) 2015-09-11 2017-03-16 Bayer Cropscience Aktiengesellschaft Hppd variants and methods of use
WO2017184727A1 (en) 2016-04-21 2017-10-26 Bayer Cropscience Lp Tal-effector mediated herbicide tolerance
KR20190008933A (en) 2016-05-24 2019-01-25 몬산토 테크놀로지 엘엘씨 Plant regulatory elements and their uses
US10351866B2 (en) 2016-05-24 2019-07-16 Monsanto Technology Llc Plant regulatory elements and uses thereof
WO2017205287A1 (en) * 2016-05-24 2017-11-30 Monsanto Technology Llc Plant regulatory elements and uses thereof
EP3269816A1 (en) 2016-07-11 2018-01-17 Kws Saat Se Development of fungal resistant crops by higs (host-induced gene silencing) mediated inhibition of gpi-anchored cell wall protein synthesis
WO2018011082A1 (en) 2016-07-11 2018-01-18 Kws Saat Se Development of fungal resistant crops by higs (host-induced gene silencing) mediated inhibition of gpi-anchored cell wall protein synthesis
WO2018098214A1 (en) 2016-11-23 2018-05-31 Bayer Cropscience Lp Axmi669 and axmi991 toxin genes and methods for their use
WO2018119336A1 (en) 2016-12-22 2018-06-28 Athenix Corp. Use of cry14 for the control of nematode pests
WO2018136611A1 (en) 2017-01-18 2018-07-26 Bayer Cropscience Lp Use of bp005 for the control of plant pathogens
WO2018136604A1 (en) 2017-01-18 2018-07-26 Bayer Cropscience Lp Bp005 toxin gene and methods for its use
WO2018165091A1 (en) 2017-03-07 2018-09-13 Bayer Cropscience Lp Hppd variants and methods of use
WO2019083808A1 (en) 2017-10-24 2019-05-02 Basf Se Improvement of herbicide tolerance to hppd inhibitors by down-regulation of putative 4-hydroxyphenylpyruvate reductases in soybean
WO2019083810A1 (en) 2017-10-24 2019-05-02 Basf Se Improvement of herbicide tolerance to 4-hydroxyphenylpyruvate dioxygenase (hppd) inhibitors by down-regulation of hppd expression in soybean

Also Published As

Publication number Publication date
AU672949B2 (en) 1996-10-24
CA2107583A1 (en) 1992-10-09
IE921108A1 (en) 1992-10-21
AU1681992A (en) 1992-11-02
UA44217C2 (en) 2002-02-15
JPH06509939A (en) 1994-11-10
ZA922542B (en) 1992-12-30
US5905186A (en) 1999-05-18
IL101508A0 (en) 1992-12-30
KR100228918B1 (en) 1999-12-01
BR9205873A (en) 1994-08-23
US5859325A (en) 1999-01-12
EP0579726A4 (en) 1995-04-19
EP0579726A1 (en) 1994-01-26
MX9201592A (en) 1992-10-01

Similar Documents

Publication Publication Date Title
US5905186A (en) Chimeric plant genes based on upstream regulatory elements of helianthinin
US6407315B1 (en) Seed-preferred promoter from barley
Oommen et al. The elicitor-inducible alfalfa isoflavone reductase promoter confers different patterns of developmental expression in homologous and heterologous transgenic plants.
AU4017801A (en) Seed-preferred promoter from maize
CA2078229A1 (en) Plant promoter
US20040244072A1 (en) Leaf specific gene promoter of coffee
US5750399A (en) Isoflavone reductase promoter
US6921815B2 (en) Cytokinin Oxidase Promoter from Maize
US5824872A (en) A constitutive promoter from tobacco
US6518484B2 (en) Promoter system of plant translationally controlled tumor protein gene
US8044263B2 (en) Cytokinin oxidase promoter from maize
US7557264B2 (en) Gossypium hirsutum tissue-specific promoters and their use
US5824865A (en) Chimeric plant genes based on upstream regulatory elements of helianthinin
CA2168617C (en) Constitutive promoter from tobacco
PT100805B (en) NUCLEIC ACID ISOLATED FROM A GENE OF HELIANTININ AND CHIMERIC GENES OF PLANTS BASED ON HELIANTININE ELEMENTS REGULATORS AT THE AMOUNT
WO2001036649A2 (en) Isolation and characterization of the genomic dna clones of ribosomal protein gene l25 in tobacco
CA2389759A1 (en) Seed-preferred promoter from barley

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU BR CA JP KR US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH DE DK ES FR GB GR IT LU MC NL SE

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
EX32 Extension under rule 32 effected after completion of technical preparation for international publication
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
WWE Wipo information: entry into national phase

Ref document number: 2107583

Country of ref document: CA

WWE Wipo information: entry into national phase

Ref document number: 1992909899

Country of ref document: EP

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
WWP Wipo information: published in national office

Ref document number: 1992909899

Country of ref document: EP

LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
LE32 Later election for international application filed prior to expiration of 19th month from priority date or according to rule 32.2 (b)
WWW Wipo information: withdrawn in national office

Ref document number: 1992909899

Country of ref document: EP